These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 2643213)
21. High risk of mother-to-child transmission of HTLV-I in p40tax antibody-positive mothers. Sawada T; Tohmatsu J; Obara T; Koide A; Kamihira S; Ichimaru M; Kashiwagi S; Kajiyama W; Matsumura N; Kinoshita K Jpn J Cancer Res; 1989 Jun; 80(6):506-8. PubMed ID: 2503470 [TBL] [Abstract][Full Text] [Related]
22. Lookback study of HTLV-1 and 2 seropositive donors and their recipients in Belo Horizonte, Brazil. Namen-Lopes MS; Martins ML; Drummond PC; Lobato RR; ; Carneiro-Proietti AB Transfus Med; 2009 Aug; 19(4):180-8. PubMed ID: 19706135 [TBL] [Abstract][Full Text] [Related]
23. Human T-lymphotropic virus type I and type II infections and correlation with risk factors in blood donors from São Paulo, Brazil. Ferreira Júnior OC; Vaz RS; Carvalho MB; Guerra C; Fabron AL; Rosemblit J; Hamerschlak N Transfusion; 1995 Mar; 35(3):258-63. PubMed ID: 7878720 [TBL] [Abstract][Full Text] [Related]
24. Preliminary survey of anti-HTLV-I in northeastern-Thais. Burusrux S; Urwijitaroon Y; Romphruk A; Puapairoj C J Med Assoc Thai; 1995 Nov; 78(11):628-30. PubMed ID: 8576676 [TBL] [Abstract][Full Text] [Related]
25. Transmission of HTLV-I to rabbits via semen and breast milk from seropositive healthy persons. Iwahara Y; Takehara N; Kataoka R; Sawada T; Ohtsuki Y; Nakachi H; Maehama T; Okayama T; Miyoshi I Int J Cancer; 1990 May; 45(5):980-3. PubMed ID: 2185996 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of the human T-cell leukemia virus type I seropositivity of blood donors by the particle agglutination inhibition test. Kwon KW; Ikeda H; Yano M; Sekiguchi S Jpn J Cancer Res; 1989 Sep; 80(9):833-9. PubMed ID: 2513300 [TBL] [Abstract][Full Text] [Related]
27. [Screening of antibodies to human T-cell leukemia virus type I (HTLV-I) in sera of blood donors and comparison of different methods]. Fan FS; Lin DL; Yeh HM; Chen MS; Su JL; Lin SH; Tzeng CH; Chuang MW; Liu JH; Hsieh RK Zhonghua Yi Xue Za Zhi (Taipei); 1989 Jul; 44(1):71-6. PubMed ID: 2684368 [TBL] [Abstract][Full Text] [Related]
28. A cluster of human T-lymphotropic virus type-I carriers found in the southern district of Tokushima Prefecture. Kosaka M; Iishi Y; Horiuchi N; Nakao K; Okagawa K; Saito S; Minami Y; Katoh K Jpn J Clin Oncol; 1989 Mar; 19(1):30-5. PubMed ID: 2646467 [TBL] [Abstract][Full Text] [Related]
29. Bottle-feeding can prevent transmission of HTLV-I from mothers to their babies. Ando Y; Saito K; Nakano S; Kakimoto K; Furuki K; Tanigawa T; Hashimoto H; Moriyama I; Ichijo M; Toyama T J Infect; 1989 Jul; 19(1):25-9. PubMed ID: 2778340 [TBL] [Abstract][Full Text] [Related]
30. Transfusion-associated transmission of human T-lymphotropic virus types I and II: experience of a regional blood center. Herr V; Ambruso D; Fairfax M; Neumann A; Swanson P; Lee H Transfusion; 1993 Mar; 33(3):208-11. PubMed ID: 8438220 [TBL] [Abstract][Full Text] [Related]
31. Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London. Brennan M; Runganga J; Barbara JA; Contreras M; Tedder RS; Garson JA; Tuke PW; Mortimer PP; McAlpine L; Tosswill JH BMJ; 1993 Nov; 307(6914):1235-9. PubMed ID: 8281054 [TBL] [Abstract][Full Text] [Related]
32. Transfusion-transmitted human T-cell lymphotropic virus type I infection in Taiwan: a true risk and occasional coinfection with hepatitis C virus shown in a prospective study. Wang JT; Lin MT; Chen PJ; Sheu JC; Lin JT; Wang TH; Chen DS Blood; 1994 Aug; 84(3):934-40. PubMed ID: 7913844 [TBL] [Abstract][Full Text] [Related]
33. Transfusion-transmitted HTLV-I/II infection in patients undergoing open-heart surgery. Shih JW; Lee HH; Falchek M; Canavaggio M; Jett BW; Allain JP; Alter HJ Blood; 1990 Feb; 75(3):546-9. PubMed ID: 2297566 [TBL] [Abstract][Full Text] [Related]
34. The outcome of donor screening for human T-cell lymphotropic virus infection in The Netherlands. Prinsze FJ; Zaaijer HL Vox Sang; 2012 Apr; 102(3):198-203. PubMed ID: 21895678 [TBL] [Abstract][Full Text] [Related]
35. Decline in the positive rate of human T-lymphotropic virus type-1 (HTLV-1) antibodies among blood donors in Nagasaki. Chiyoda S; Kinoshita K; Egawa S; Inoue J; Watanabe K; Ifuku M Intern Med; 2001 Jan; 40(1):14-7. PubMed ID: 11201362 [TBL] [Abstract][Full Text] [Related]
37. International forum: Saudi Arabia. Donor screening for HTLV-I in Saudi Arabia: is it cost effective? Bernvil SS; Andrews V; Coulter N Transfus Sci; 1997 Mar; 18(1):45-7. PubMed ID: 10174291 [TBL] [Abstract][Full Text] [Related]
38. Effectiveness of human T-lymphotropic virus (HTLV) recipient tracing (lookback) and the current HTLV-I and -II confirmatory algorithm, 1999 to 2004. Stramer SL; Foster GA; Dodd RY Transfusion; 2006 May; 46(5):703-7. PubMed ID: 16686837 [TBL] [Abstract][Full Text] [Related]
39. Prevention of transmission of human T-cell lymphotropic virus type-I by blood transfusion by screening of donors. Nishimura Y; Yamaguchi K; Kiyokawa T; Takatsuki K; Imamura Y; Fujiwara H Transfusion; 1989 May; 29(4):372. PubMed ID: 2718239 [No Abstract] [Full Text] [Related]
40. Saudi National Guard donor screening for human T cell lymphotropic virus I/II: time to use molecular biology techniques. Balkhy HH; Memish ZA; Abed E; Qasem L; Amer AB; Masoud S; Hajeer AH Mil Med; 2004 Mar; 169(3):251-3. PubMed ID: 15080248 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]